FDA Commissioner: Martin Makary Sworn In
- Makary,a surgeon-scientist and health policy expert,has been sworn in as the 27th Commissioner of Food and Drugs after a bipartisan Senate vote.
- Makary, emphasizing his qualifications to lead the FDA.
- Makary's career includes authoring over 300 peer-reviewed articles and founding the Johns Hopkins Center for Surgical Trials and Outcomes Research.
Dr. Martin Makary, a renowned health policy expert, now leads the FDA as its new commissioner, marking a significant shift in the agency’s leadership. Makary vows to inject trusted science and unwavering clarity into the FDA’s core, prioritizing public health above all else. His extensive background includes over 300 peer-reviewed articles and the founding of the Johns Hopkins Center for Surgical Trials and Outcomes Research, highlighting his expertise in research and clinical practice. Secretary Kennedy commended Makary’s unparalleled qualifications, setting the stage for an exciting new chapter.This move underscores a commitment to excellence that News Directory 3 is following closely. Discover what advancements and reforms Makary will implement.
Martin Makary Named FDA Commissioner,Aims for Healthcare Excellence
Updated April 01,2025
Dr. martin A. Makary,a surgeon-scientist and health policy expert,has been sworn in as the 27th Commissioner of Food and Drugs after a bipartisan Senate vote. He brings extensive experience in research,clinical practice,and health policy to the Food and Drug Governance.
Health and Human Services Secretary Robert F. Kennedy Jr. welcomed Dr. Makary, emphasizing his qualifications to lead the FDA. Kennedy said Makary’s research and leadership make him uniquely suited to “Make America Healthy Again.”
Makary’s career includes authoring over 300 peer-reviewed articles and founding the Johns Hopkins Center for Surgical Trials and Outcomes Research. His research spans cancer care, obesity, Alzheimer’s, and adverse event monitoring. He also co-developed the Surgery Checklist,now used globally.
the new FDA commissioner is a member of the National Academy of Medicine and has been a visiting professor at over 25 medical schools. He is a graduate of Bucknell University, Thomas Jefferson University, and the Harvard School of Public Health.
Makary completed his residency at Georgetown University and a surgical oncology fellowship at Johns Hopkins. He later became a professor at Johns Hopkins, holding appointments at the School of Public Health and the Carey Business School.
“I am honored and humbled to assume this role at the FDA under the leadership of president Trump and Secretary Kennedy,” said FDA Commissioner Martin A. Makary, M.D., M.P.H. “I look forward to working with this Administration and the FDA workforce to advance our shared goals in meeting the agency’s public health mission.As Commissioner, I hope to ensure that the FDA holds to the gold standard of trusted science, transparency, and common sense so that we can Make America Healthy Again.”
What’s next
As commissioner, Dr. Martin Makary is expected to focus on upholding scientific standards and increasing transparency within the FDA to enhance public health and safety.